Effect of Nitinol on Metabolic and Coagulation Activity of Endothelial Cells Culture
© 2021. Springer Science+Business Media, LLC, part of Springer Nature..
We studied the effect of nitinol, the most prevalent material for endovascular stents, on metabolic and coagulation activity of a primary culture of human umbilical vein endothelial cells (HUVEC). Metabolic activity was evaluated using MTS-test and by the level of stable NO metabolites in the conditioned medium, coagulation activity was assessed by activity of von Willebrand factor (vWF) and levels of plasminogen activator inhibitor-1 (PAI-1) and soluble endothelial protein C receptors (sEPCR). Exposure to nitinol reduced metabolic activity of the cell culture by 11.1% in comparison with the control (p<0.001). Although absolute activity of vWF and absolute level of sEPCR were elevated, incubation with nitinol did not lead to a statistically significant elevation of these parameters in comparison with the control, which can indicate the absence of substantial hypercoagulation effects of nitinol.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:171 |
|---|---|
| Enthalten in: |
Bulletin of experimental biology and medicine - 171(2021), 4 vom: 20. Aug., Seite 480-482 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kalinin, R E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2EWL73IJ7F |
|---|
| Anmerkungen: |
Date Completed 31.01.2022 Date Revised 31.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10517-021-05255-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330846469 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330846469 | ||
| 003 | DE-627 | ||
| 005 | 20231225212150.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10517-021-05255-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330846469 | ||
| 035 | |a (NLM)34542754 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kalinin, R E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Nitinol on Metabolic and Coagulation Activity of Endothelial Cells Culture |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.01.2022 | ||
| 500 | |a Date Revised 31.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a We studied the effect of nitinol, the most prevalent material for endovascular stents, on metabolic and coagulation activity of a primary culture of human umbilical vein endothelial cells (HUVEC). Metabolic activity was evaluated using MTS-test and by the level of stable NO metabolites in the conditioned medium, coagulation activity was assessed by activity of von Willebrand factor (vWF) and levels of plasminogen activator inhibitor-1 (PAI-1) and soluble endothelial protein C receptors (sEPCR). Exposure to nitinol reduced metabolic activity of the cell culture by 11.1% in comparison with the control (p<0.001). Although absolute activity of vWF and absolute level of sEPCR were elevated, incubation with nitinol did not lead to a statistically significant elevation of these parameters in comparison with the control, which can indicate the absence of substantial hypercoagulation effects of nitinol | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a HUVEC | |
| 650 | 4 | |a PAI-1 | |
| 650 | 4 | |a nitinol | |
| 650 | 4 | |a sEPCR | |
| 650 | 4 | |a von Willebrand factor | |
| 650 | 7 | |a Alloys |2 NLM | |
| 650 | 7 | |a Blood Coagulation Factors |2 NLM | |
| 650 | 7 | |a Endothelial Protein C Receptor |2 NLM | |
| 650 | 7 | |a Plasminogen Activator Inhibitor 1 |2 NLM | |
| 650 | 7 | |a von Willebrand Factor |2 NLM | |
| 650 | 7 | |a nitinol |2 NLM | |
| 650 | 7 | |a 2EWL73IJ7F |2 NLM | |
| 700 | 1 | |a Suchkov, I A |e verfasserin |4 aut | |
| 700 | 1 | |a Mzhavanadze, N D |e verfasserin |4 aut | |
| 700 | 1 | |a Korotkova, N V |e verfasserin |4 aut | |
| 700 | 1 | |a Zhurina, O N |e verfasserin |4 aut | |
| 700 | 1 | |a Povarov, V O |e verfasserin |4 aut | |
| 700 | 1 | |a Surov, I Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Bozhenova, A D |e verfasserin |4 aut | |
| 700 | 1 | |a Strelnikova, E A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bulletin of experimental biology and medicine |d 1974 |g 171(2021), 4 vom: 20. Aug., Seite 480-482 |w (DE-627)NLM000481815 |x 1573-8221 |7 nnns |
| 773 | 1 | 8 | |g volume:171 |g year:2021 |g number:4 |g day:20 |g month:08 |g pages:480-482 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10517-021-05255-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 171 |j 2021 |e 4 |b 20 |c 08 |h 480-482 | ||